Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome

The association between nephrotic syndrome (NS) and a hypercoagulable state has been demonstrated. Controlling the blood clotting activity may therefore be attractive for patients with nephrosis in terms of thromboembolism prophylaxis. We herein report a 75-year-old woman with minimal change disease who developed pains in the right back, groin, and thigh because of retroperitoneal bleeding during prophylactic anticoagulation with unfractionated heparin. Although this procedure has not been accepted as the standard of care for patients with nephrosis, pharmacologic prophylaxis may already be practiced empirically, as in the present patient. We believe that our experience highlights the pitfalls of such a management in patients with nephrosis, implying the need for a diagnostic strategy for identifying those patients with NS who can benefit from prophylactic anticoagulation. Several concerns that emerged in this case are also discussed.

[1]  Xiang-mei Chen,et al.  Impact of acute kidney injury on coagulation in adult minimal change nephropathy , 2016, Medicine.

[2]  E. Kusano,et al.  Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury , 2016, Clinical medicine insights. Case reports.

[3]  Anne E Rose,et al.  Anticoagulation Management , 2015, Springer International Publishing.

[4]  J. Levy,et al.  Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[5]  R. Jain,et al.  Bilateral iliopsoas hematoma: Case report and literature review , 2013, Surgical neurology international.

[6]  Kathleen J Pincus,et al.  Prophylaxis of Thromboembolic Events in Patients with Nephrotic Syndrome , 2013, The Annals of pharmacotherapy.

[7]  H. Sugimoto,et al.  Flank pain, nausea, vomiting and hypotension in a chronic hemodialysis patient with a spontaneous perirenal hemorrhage. , 2013, Internal medicine.

[8]  Daniel Cabrera,et al.  Spontaneous retroperitoneal hematoma: etiology, characteristics, management, and outcome. , 2012, The Journal of emergency medicine.

[9]  B. Kerlin,et al.  Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[10]  T. Baglin,et al.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[11]  D. Jin,et al.  Transcatheter Arterial Embolization as Treatment for a Life-Threatening Retroperitoneal Hemorrhage Complicating Heparin Therapy , 2011, The Korean journal of internal medicine.

[12]  H. Chen,et al.  Nephrotic Syndrome Complicated by Life‐Threatening Pulmonary Embolism in an Adult Patient , 2010, The Kaohsiung journal of medical sciences.

[13]  J. Reidy,et al.  Management of spontaneous and iatrogenic retroperitoneal haemorrhage: conservative management, endovascular intervention or open surgery? , 2007, International journal of clinical practice.

[14]  K. Tsuchiya,et al.  Fatal diffuse pulmonary arterial thrombosis as a complication of nephrotic syndrome , 2007, Clinical and Experimental Nephrology.

[15]  R. Glassock.  Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. , 2007, Journal of the American Society of Nephrology : JASN.

[16]  V. D’Agati,et al.  Adult minimal-change disease: clinical characteristics, treatment, and outcomes. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[17]  R. Fairman,et al.  Femoral Neuropathy following Retroperitoneal Hemorrhage: Case Series and Review of the Literature , 2006, Annals of vascular surgery.

[18]  K. S. Brimble,et al.  Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. , 2006, Thrombosis research.

[19]  Y. Wada,et al.  Bilateral iliopsoas hematomas complicating anticoagulant therapy. , 2005, Internal medicine.

[20]  L. Fares,et al.  A Retroperitoneal Bleed Induced by Enoxaparin Therapy , 2005, The American surgeon.

[21]  J. Riancho,et al.  The Clinical Spectrum of Retroperitoneal Hematoma in Anticoagulated Patients , 2003, Medicine.

[22]  Z. Sasson,et al.  Spontaneous iliopsoas hematoma in patients with unstable coronary syndromes receiving intravenous heparin in therapeutic doses. , 1996, The Canadian journal of cardiology.

[23]  P. Abbitt,et al.  Iliopsoas compartment: normal anatomy and pathologic processes. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[24]  L. Lenchik,et al.  CT of the iliopsoas compartment: value in differentiating tumor, abscess, and hematoma. , 1994, AJR. American journal of roentgenology.

[25]  F. M. Schroeder,et al.  Anticoagulants, iliopsoas hematoma and femoral nerve compression. , 1991, American family physician.

[26]  L. Woldenberg,et al.  Percutaneous decompression for femoral neuropathy secondary to heparin-induced retroperitoneal hematoma: case report and review of the literature. , 1991, The American surgeon.

[27]  McCort Jj.  Intraperitoneal and retroperitoneal hemorrhage. , 1976 .

[28]  J. McCort.  Intraperitoneal and retroperitoneal hemorrhage. , 1976, Radiologic clinics of North America.